Our approach uses the targeted delivery of iNOS plasmids that are transfected into the tumor vasculature using focused ultrasound (FUS) and custom ultrasound contrast agents (UCAs) called “microbubbles”. The gene discussed is NOS2; the disease is neoplasm.